ascorbic-acid has been researched along with Tachycardia* in 6 studies
1 trial(s) available for ascorbic-acid and Tachycardia
Article | Year |
---|---|
NaHCO
The study aimed to investigate if vegetable-based high-energy mash diets supplemented with NaHCO Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Arginine; Ascorbic Acid; Chickens; Diet; Dietary Supplements; Polycythemia; Tachycardia; Vegetables | 2022 |
5 other study(ies) available for ascorbic-acid and Tachycardia
Article | Year |
---|---|
C for colored urine: acute hemolysis induced by high-dose ascorbic acid.
Topics: Acute Disease; Ascorbic Acid; Dose-Response Relationship, Drug; Erythrocytes; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Infant; Male; Tachycardia | 2014 |
Enhancement of glutathione cardioprotection by ascorbic acid in myocardial reperfusion injury.
The present experiment determined the effects of glutathione and ascorbic acid, the two most important hydrophilic antioxidants, on myocardial ischemia-reperfusion injury and evaluated their relative therapeutic values. Isolated rat hearts were subjected to ischemia (30 min) and reperfusion (120 min) and treated with ascorbic acid, glutathione monoethyl ester (GSHme), or their combination at the onset of reperfusion. Administration of 1 mM GSHme alone, but not 1 mM ascorbic acid alone, significantly attenuated postischemic injury (P < 0.05 versus vehicle). Most interestingly, coadministration of ascorbic acid with GSHme markedly enhanced the protective effects of GSHme (P < 0.01 versus vehicle). The protection exerted by the combination of GSHme and ascorbic acid at 1 mM each was significantly greater than that observed with 1 mM GSHme alone (P < 0.05). Moreover, treatment with GSHme alone or GSHme plus ascorbic acid markedly reduced myocardial nitrotyrosine levels, suggesting that these treatments attenuated myocardial peroxynitrite formation. These results demonstrated that 1) GSHme, but not ascorbic acid, exerted protective effects against ischemia-reperfusion injury; and 2) the protective effects of GSHme were further enhanced by coadministration with ascorbic acid, suggesting a synergistic effect between GSHme and ascorbic acid. Topics: Animals; Antioxidants; Ascorbic Acid; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Glutathione; Heart; Heart Rate; Incidence; Lipid Peroxidation; Myocardial Reperfusion Injury; Myocardium; Protective Agents; Rats; Reperfusion Injury; Tachycardia; Tyrosine; Ventricular Fibrillation | 2002 |
[Intoxication by hydrogen sulfide in a natural gas refinery].
Topics: Accidents, Occupational; Ascorbic Acid; Coma; Cyanosis; Environmental Exposure; Euphoria; Gastrointestinal Diseases; Humans; Hydrogen Sulfide; Nausea; Occupational Diseases; Oxygen Inhalation Therapy; Petroleum; Respiratory Tract Diseases; Tachycardia | 1974 |
[Thyrotoxic crisis: symptoms and therapy (author's transl)].
Topics: Adult; Aged; Ascorbic Acid; Body Temperature; Contrast Media; Female; First Aid; Germany, West; Humans; Iodides; Iodine; Male; Methimazole; Middle Aged; Phenobarbital; Prednisolone; Tachycardia; Thyroid Crisis; Triiodothyronine | 1973 |
[ENDOCARDIAL FIBROELASTOSIS IN CHILDHOOD].
Topics: Adrenal Cortex Hormones; Ascorbic Acid; Balsams; Central Nervous System Stimulants; Digitalis; Digitalis Glycosides; Electrocardiography; Endocardial Fibroelastosis; Humans; Infant; Liver Extracts; Oxygen Inhalation Therapy; Pathology; Penicillins; Radiography, Thoracic; Streptomycin; Tachycardia | 1963 |